RARE vs ROOT · rev $560.2M vs P/E 14, rev $1.18B
Ultragenyx (RARE) versus Root Inc (ROOT) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Root Inc (ROOT) is a insurance - property & casualty company listed on NASDAQ.
Latest reported RARE revenue for 2024-12-31 was $560.2M. Net income was -$569.2M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. RARE currently screens at market cap $2.79B.
Latest reported ROOT revenue for 2024-12-31 was $1.18B. Net income was $30.9M. Revenue was up 158.6% from 2023-12-31 to 2024-12-31. ROOT currently screens at market cap $767.6M and trailing P/E 14.3.
RARE currently screens at market cap $2.79B. ROOT currently screens at market cap $767.6M and trailing P/E 14.3.
Not investment advice. Open the RARE and ROOT stock pages for the full models.
Not investment advice.